Singapore markets closed

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4344-0.0756 (-4.86%)
As of 11:28AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-27,029
-27,029
-41,307
-43,241
-5,995
Depreciation & amortisation
151
151
367
460
632
Stock-based compensation
2,147
2,147
2,692
4,232
5,747
Change in working capital
-3,594
-3,594
1,412
-3,236
1,909
Accounts receivable
562
562
-81
-507
0
Accounts payable
-451
-451
411
-1,902
1,019
Other working capital
-23,969
-23,969
-27,292
-36,720
-34,854
Net cash provided by operating activities
-23,935
-23,935
-27,023
-36,715
-34,778
Cash flows from investing activities
Investments in property, plant and equipment
-34
-34
-269
-5
-76
Purchases of investments
-47,048
-47,048
-66,191
-9,357
-42,540
Sales/maturities of investments
62,623
62,623
43,162
30,922
87,385
Net cash used for investing activities
15,541
15,541
-23,276
21,560
44,769
Cash flows from financing activities
Common stock issued
7,843
7,843
0
60,943
1,222
Net cash used provided by (used for) financing activities
7,855
7,855
0
62,158
1,310
Net change in cash
-539
-539
-50,299
47,003
11,301
Cash at beginning of period
13,159
13,159
63,458
16,455
5,154
Cash at end of period
12,620
12,620
13,159
63,458
16,455
Free cash flow
Operating cash flow
-23,935
-23,935
-27,023
-36,715
-34,778
Capital expenditure
-34
-34
-269
-5
-76
Free cash flow
-23,969
-23,969
-27,292
-36,720
-34,854